Tokyo Tape
Sign in
← Takeda Pharmaceutical

Half-year report · Q2

4502.TEDINET S100ULG6
Period2024-04-01 → 2024-09-30
Filed2024-10-31
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥2.38T2024-04-01 → 2024-09-30Cons.Revenue IFRS
Revenue¥4.26T2023-04-01 → 2024-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥2.10T2023-04-01 → 2023-09-30Cons.Revenue IFRS
Operating income¥350.6bn2024-04-01 → 2024-09-30Cons.Operating profit loss IFRS
Operating income¥119.2bn2023-04-01 → 2023-09-30Cons.Operating profit loss IFRS
Profit before tax¥256.0bn2024-04-01 → 2024-09-30Cons.Profit loss before tax IFRS
Profit before tax¥52.8bn2023-04-01 → 2024-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥39.1bn2023-04-01 → 2023-09-30Cons.Profit loss before tax IFRS
Net income (owners)¥187.3bn2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥144.1bn2023-04-01 → 2024-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥41.4bn2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income¥187.4bn2024-04-01 → 2024-09-30Cons.Profit loss IFRS
Net income¥144.2bn2023-04-01 → 2024-03-31Cons.Profit loss IFRS (5-year summary)
Net income¥41.4bn2023-04-01 → 2023-09-30Cons.Profit loss IFRS
Total assets¥14.57Tat 2024-09-30Cons.Assets IFRS
Total assets¥15.11Tat 2024-03-31Cons.Assets IFRS
Total assets¥14.87Tat 2023-09-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥7.65Tat 2024-09-30Cons.Liabilities IFRS
Total liabilities¥7.83Tat 2024-03-31Cons.Liabilities IFRS
Net assets / equity¥6.92Tat 2024-09-30Cons.Equity IFRS
Net assets / equity¥7.27Tat 2024-03-31Cons.Equity IFRS
Net assets / equity¥7.07Tat 2023-09-30Cons.Equity IFRS
Net assets / equity¥6.35Tat 2023-03-31dCons.Equity IFRS
Equity (owners)¥6.92Tat 2024-09-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥7.27Tat 2024-03-31Cons.Equity attributable to owners of parent IFRS
Cash & equivalents¥859.0bnat 2024-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥457.8bnat 2024-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥318.1bnat 2023-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥533.5bnat 2023-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥451.3bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥716.3bn2023-04-01 → 2024-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥291.3bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥231.8bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥463.9bn2023-04-01 → 2024-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥327.1bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow¥206.3bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥354.4bn2023-04-01 → 2024-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥198.4bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥118.852024-04-01 → 2024-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥92.092023-04-01 → 2024-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥26.512023-04-01 → 2023-09-30Cons.Basic earnings loss per share IFRS
EPS (diluted)¥117.112024-04-01 → 2024-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥91.162023-04-01 → 2024-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥26.292023-04-01 → 2023-09-30Cons.Diluted earnings loss per share IFRS
Equity ratio47.5%at 2024-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio48.1%at 2024-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio47.5%at 2023-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 659
ItemContextValueUnit
Equity IFRSPrior2YearInstant_CapitalSurplusIFRSMember1728830000000JPY
Equity IFRSPrior2YearInstant_TreasurySharesIFRSMember-100317000000JPY
Equity IFRSPrior2YearInstant_RetainedEarningsIFRSMember1541146000000JPY
Equity IFRSPrior2YearInstant_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember1606128000000JPY
Equity IFRSPrior2YearInstant_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember12470000000JPY
Profit loss IFRSPrior1YTDDuration_RetainedEarningsIFRSMember41365000000JPY
Other comprehensive income IFRSPrior1YTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember778851000000JPY
Other comprehensive income IFRSPrior1YTDDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember6577000000JPY
Comprehensive income IFRSPrior1YTDDuration_ShareCapitalIFRSMember－JPY
Comprehensive income IFRSPrior1YTDDuration_CapitalSurplusIFRSMember－JPY
Comprehensive income IFRSPrior1YTDDuration_TreasurySharesIFRSMember－JPY
Comprehensive income IFRSPrior1YTDDuration_RetainedEarningsIFRSMember41365000000JPY
Comprehensive income IFRSPrior1YTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember778851000000JPY
Comprehensive income IFRSPrior1YTDDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember6577000000JPY
Issuance of new shares ss IFRSPrior1YTDDuration_ShareCapitalIFRSMember158000000JPY
Issuance of new shares ss IFRSPrior1YTDDuration_CapitalSurplusIFRSMember158000000JPY
Purchase of treasury shares ss IFRSPrior1YTDDuration_TreasurySharesIFRSMember-2355000000JPY
Disposal of treasury shares ss IFRSPrior1YTDDuration_CapitalSurplusIFRSMember0JPY
Disposal of treasury shares ss IFRSPrior1YTDDuration_TreasurySharesIFRSMember0JPY
Dividends ss IFRSPrior1YTDDuration_RetainedEarningsIFRSMember-140121000000JPY
Transfer from other components of equity to retained earnings ss IFRSPrior1YTDDuration_RetainedEarningsIFRSMember3628000000JPY
Transfer from other components of equity to retained earnings ss IFRSPrior1YTDDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember-985000000JPY
Share based compensation ss IFRSPrior1YTDDuration_CapitalSurplusIFRSMember33606000000JPY
Exercise of share based awards ss IFRSPrior1YTDDuration_CapitalSurplusIFRSMember-51485000000JPY
Exercise of share based awards ss IFRSPrior1YTDDuration_TreasurySharesIFRSMember51426000000JPY
Total transactions with owners IFRSPrior1YTDDuration_ShareCapitalIFRSMember158000000JPY
Total transactions with owners IFRSPrior1YTDDuration_CapitalSurplusIFRSMember-17721000000JPY
Total transactions with owners IFRSPrior1YTDDuration_TreasurySharesIFRSMember49071000000JPY
Total transactions with owners IFRSPrior1YTDDuration_RetainedEarningsIFRSMember-136493000000JPY
Total transactions with owners IFRSPrior1YTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember－JPY
Total transactions with owners IFRSPrior1YTDDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember-985000000JPY
Equity IFRSPrior1QuarterInstant_ShareCapitalIFRSMember1676503000000JPY
Equity IFRSPrior1QuarterInstant_CapitalSurplusIFRSMember1711109000000JPY
Equity IFRSPrior1QuarterInstant_TreasurySharesIFRSMember-51246000000JPY
Equity IFRSPrior1QuarterInstant_RetainedEarningsIFRSMember1446018000000JPY
Equity IFRSPrior1QuarterInstant_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember2384979000000JPY
Equity IFRSPrior1QuarterInstant_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember18062000000JPY
Equity IFRSPrior2YearInstant_EffectivePortionOfCashFlowHedgesIFRSMember-87352000000JPY
Equity IFRSPrior2YearInstant_jpcrp040300-q2r_E00919-000HedgingCostIFRSMember-23127000000JPY
Equity IFRSPrior2YearInstant_RemeasurementsOfDefinedBenefitPlansIFRSMember－JPY
Equity IFRSPrior2YearInstant_OtherComponentsOfEquityIFRSMember1508119000000JPY
Equity IFRSPrior2YearInstant_EquityAttributableToOwnersOfParentIFRSMember6354122000000JPY
Equity IFRSPrior2YearInstant_NonControllingInterestsIFRSMember549000000JPY
Equity IFRSPrior2YearInstant6354672000000JPY
Profit loss IFRSPrior1YTDDuration_OtherComponentsOfEquityIFRSMember－JPY
Profit loss IFRSPrior1YTDDuration_EquityAttributableToOwnersOfParentIFRSMember41365000000JPY
Profit loss IFRSPrior1YTDDuration_NonControllingInterestsIFRSMember71000000JPY
Profit loss IFRSPrior1YTDDuration41436000000JPY
Other comprehensive income IFRSPrior1YTDDuration_EffectivePortionOfCashFlowHedgesIFRSMember-2015000000JPY
Other comprehensive income IFRSPrior1YTDDuration_jpcrp040300-q2r_E00919-000HedgingCostIFRSMember-2579000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2024-03-31pass rounding
balance sheet identityconsolidated 2024-09-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · total assetsconsolidated 2024-03-31pass
statement vs summary · total assetsconsolidated 2024-09-30pass